coupling ricin to mouse anti-human CD38 monoclonal antibody HB7, the antibody-drug conjugate exhibited stronger activity killing positive
by MV Mateos 2024 Cited by 2feasibility of switching anti-CD38 drugs in patients who have not benefitted from previous treatment with anti-CD38 monoclonal antibodies.
An anti-CD38 monoclonal antibody like daratumumab (Darzalex). This targets a protein on the surface of myeloma cells called CD38. A
Anti-CD38 monoclonal antibody may block the CD38 protein and help the immune system kill cancer cells.
There are currently two anti-CD38 monoclonal antibodies approved by the Food and Drug Administration, daratumumab and isatuximab. However
Knowledge on rare diseases and orphan drugs Search for an orphan drug Anti-CD38 IgG4 human monoclonal antibody.
Anti-CD38 monoclonal antibodies represent an important advance in the treatment of multiple myeloma Combinations With Immunomodulatory Drugs
Keywords: anti-CD38 monoclonal antibodies, CD38, daratumumab, isatuximab, MOR202, multiple myeloma. gov/drugs/resources-information
This is why anti-CD38 monoclonal antibodies induce agglutination in IAT. Indirect antiglobulin test uses normal RBCs to detect incomplete antibodies in serum. Following the administration of an anti-CD38 monoclonal antibody, the anti-CD38 monoclonal antibody in serum will play the role of incomplete antibodies.
Comments